Center for iPS Cell Research Application (CiRA) of Kyoto University and Takeda Pharmaceutical will work together to develop clinical applications of induced pluripotent stem cells Read the full story

BioXcel has entered into a partnership with Takeda Development Center Americas for the repurposing of assets across the gamut of rare diseases Read the full story

Takeda has licensed exclusive rights to use ImmunoGen’s ADC technology – including ImmunoGen’s new DNA-acting IGN payload agents Read the full story

Mersana Therapeutics have expanded their ongoing collaboration with Takeda Pharmaceutical to create novel Fleximer antibody-drug conjugate (ADC) drug candidates to include additional oncology-relevant targets Read the full story

GE Healthcare and Takeda Pharmaceutical have entered into an alliance agreement for research and development in the field of hepatic fibrosis Read the full story

MacroGenics and Takeda Pharmaceutical announced inking a pharma licensing deal to develop and commercialize four potential product candidates. Read the full story

C4X Discovery biopharma partners by signing a research collaboration agreement with Takeda Cambridge Limited. Read the full story

Takeda Pharmaceuticals is a top pharmaceutical company based in Osaka, Japan Read the full story

The term 'top pharma' can relate to the top pharmaceutical companies or the top 10 or 50... Read the full story

MacroGenics and Takeda Pharmaceutical have entered into an option agreement for pharma deal for the development and commercialization of MGD010. Read the full story